These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
897 related articles for article (PubMed ID: 23151088)
61. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951 [TBL] [Abstract][Full Text] [Related]
62. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP. Weng L; Qiu K; Gao W; Shi C; Shu F BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827 [TBL] [Abstract][Full Text] [Related]
63. MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer. Li Q; Wu X; Guo L; Shi J; Li J FEBS Open Bio; 2019 Nov; 9(11):1983-1993. PubMed ID: 31587474 [TBL] [Abstract][Full Text] [Related]
64. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p. Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891 [TBL] [Abstract][Full Text] [Related]
65. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation. Gao P; Wang Z; Hu Z; Jiao X; Yao Y J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319 [TBL] [Abstract][Full Text] [Related]
66. MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4. Chen T; Gao F; Feng S; Yang T; Chen M Oncol Rep; 2015 Jul; 34(1):461-8. PubMed ID: 25976502 [TBL] [Abstract][Full Text] [Related]
67. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients. Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752 [TBL] [Abstract][Full Text] [Related]
68. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression. Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417 [TBL] [Abstract][Full Text] [Related]
70. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2. Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230 [TBL] [Abstract][Full Text] [Related]
71. Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers. Liu Z; Mai C; Yang H; Zhen Y; Yu X; Hua S; Wu Q; Jiang Q; Zhang Y; Song X; Fang W J Cell Mol Med; 2014 Aug; 18(8):1667-79. PubMed ID: 24976536 [TBL] [Abstract][Full Text] [Related]
72. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667 [TBL] [Abstract][Full Text] [Related]
73. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2. Wang LL; Zhang M Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7760-7767. PubMed ID: 30536321 [TBL] [Abstract][Full Text] [Related]
74. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. Feng B; Wang R; Chen LB Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675 [TBL] [Abstract][Full Text] [Related]
75. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc. Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966 [TBL] [Abstract][Full Text] [Related]
76. MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer. Jiang W; He Y; Shi Y; Guo Z; Yang S; Wei K; Pan C; Xia Y; Chen Y Cell Biol Int; 2019 Mar; 43(3):253-264. PubMed ID: 30549141 [TBL] [Abstract][Full Text] [Related]
77. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
78. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555 [TBL] [Abstract][Full Text] [Related]
79. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1. Zhao TF; Wang SY; Zou XZ; Zhao HD Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105 [TBL] [Abstract][Full Text] [Related]
80. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells. Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]